Literature DB >> 12429526

The mechanism of inhibition of HIV-1 env-mediated cell-cell fusion by recombinant cores of gp41 ectodomain.

Ruben M Markosyan1, Xiuwen Ma, Min Lu, Fredric S Cohen, Grigory B Melikyan.   

Abstract

N36(L6)C34 is a recombinant protein that forms a six-helix bundle with high thermal stability. It consists of the N-terminal heptad-repeat region (N36 peptide) and the C-terminal heptad-repeat region (C34) of HIV-1 gp41, connected by six polar amino acids. The protein inhibits HIV-1 envelope-induced membrane fusion. Whether inhibition occurs while N36(L6)C34 is in its six-helix bundle configuration was investigated. Mutating a critical residue within the N36 region to promote dissociation of C34 from the grooves of the N36 coiled coil reduced bundle stability and increased the inhibition of fusion. In contrast, mutating a key residue within the C34 region to reduce bundle stability decreased inhibitory potency. The data provide strong evidence that the proteins inhibit fusion while they expose their C34 segments, rather than as six-helix bundles. Thus, despite high thermal stability of the bundle, the recombinants' less folded structures are present in sufficient concentration to inhibit fusion at physiological temperatures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429526     DOI: 10.1006/viro.2002.1593

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

Review 1.  The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement.

Authors:  F S Cohen; G B Melikyan
Journal:  J Membr Biol       Date:  2004-05-01       Impact factor: 1.843

2.  The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.

Authors:  Levon G Abrahamyan; Samvel R Mkrtchyan; James Binley; Min Lu; Grigory B Melikyan; Fredric S Cohen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.

Authors:  Jing-He Huang; Heng-Wen Yang; Shuwen Liu; Jing Li; Shibo Jiang; Ying-Hua Chen
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

4.  A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.

Authors:  Lifeng Cai; Miriam Gochin
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

5.  Swapped-domain constructs of the glycoprotein-41 ectodomain are potent inhibitors of HIV infection.

Authors:  Shidong Chu; Hardeep Kaur; Ariana Nemati; Joseph D Walsh; Vivian Partida; Shao-Qing Zhang; Miriam Gochin
Journal:  ACS Chem Biol       Date:  2015-02-17       Impact factor: 5.100

6.  Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

Authors:  Lingling Sun; Catherine M Finnegan; Tina Kish-Catalone; Robert Blumenthal; Paolo Garzino-Demo; Gian M La Terra Maggiore; Sid Berrone; Carol Kleinman; Zhibin Wu; Sayed Abdelwahab; Wuyuan Lu; Alfredo Garzino-Demo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  A novel view of modelling interactions between synthetic and biological polymers via docking.

Authors:  Vladimir B Tsvetkov; Alexander V Serbin
Journal:  J Comput Aided Mol Des       Date:  2012-12-13       Impact factor: 3.686

Review 8.  Amphipathic properties of HIV-1 gp41 fusion inhibitors.

Authors:  Miriam Gochin; Guangyan Zhou
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

9.  A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.

Authors:  R M Markosyan; P Bates; F S Cohen; G B Melikyan
Journal:  Biophys J       Date:  2004-08-31       Impact factor: 4.033

10.  Role of a putative gp41 dimerization domain in human immunodeficiency virus type 1 membrane fusion.

Authors:  Jie Liu; Yiqun Deng; Qunnu Li; Antu K Dey; John P Moore; Min Lu
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.